All Stories

  1. Opioid Discussion in the Twittersphere
  2. The Impact of Hospital Closures and Hospital and Population Characteristics on Increasing Emergency Department Volume: A Geographic Analysis
  3. Comparative Effectiveness And Cost-Effectiveness Analyses Frequently Agree On Value
  4. Most Uninsured Adults Could Schedule Primary Care Appointments Before The ACA, But Average Price Was $160
  5. Appointment Availability after Increases in Medicaid Payments for Primary Care
  6. 86. Inpatient Hospitalizations Among Insured Young Adults, 2012-2013, United States
  7. Understanding sampling uncertainty: the concepts
  8. Assessing quality-adjusted life years
  9. Analyzing cost
  10. Analyzing censored cost
  11. Valuing medical service use
  12. Introduction to economic evaluations in clinical trials
  13. Sampling uncertainty: calculation, sample size and power, and decision criteria
  14. Transferability of the results from trials
  15. Designing economic evaluations in clinical trials
  16. Comparing cost and effect: point estimates for cost-effectiveness ratios and net monetary benefit
  17. Relevance of trial-based economic analyses
  18. Economic Evaluation in Clinical Trials
  19. Access Points for the Underserved
  20. The Zigzagging zeitgeist of health services research: Rapidly changing priorities in the field
  21. Primary Care Access for New Patients on the Eve of Health Care Reform
  22. The effect of entry regulation in the health care sector: The case of home health
  23. Cross Border Effects of State Health Technology Regulation
  24. Prevalence and patterns of cooking dinner at home in the USA: National Health and Nutrition Examination Survey (NHANES) 2007–2008
  25. Electrocardiographic Screening for Hypertrophic Cardiomyopathy and Long QT Syndrome: The Drivers of Cost-Effectiveness for the Prevention of Sudden Cardiac Death
  26. Pharmacoeconomics: Economic Evaluation of Pharmaceuticals
  27. Impact of Minimally Invasive Surgery on Medical Spending and Employee Absenteeism
  28. Radical Cystectomy versus Bladder-Preserving Therapy for Muscle-Invasive Urothelial Carcinoma: Examining Confounding and Misclassification Biasin Cancer Observational Comparative Effectiveness Research
  29. Pharmacoeconomics: Economic Evaluation of Pharmaceuticals
  30. Shipping out instead of shaping up: Rehospitalization from nursing homes as an unintended effect of public reporting
  31. Are the Healthy Behaviors of US High-Deductible Health Plan Enrollees Driven by People Who Chose These Plans? Smoking as a Case Study
  32. The Effect of Pay-for-Performance in Nursing Homes: Evidence from State Medicaid Programs
  33. High deductible health plans: does cost sharing stimulate increased consumer sophistication?
  34. Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults
  35. The Impact of Hospital Pay‐for‐Performance on Hospital and Medicare Costs
  36. Near/far matching: a study design approach to instrumental variables
  37. Academic Medical Centers and Equity in Specialty Care Access for Children
  38. Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: An example from the NIDA Clinical Trials Network
  39. Cost-Effectiveness of Long-Term Outpatient Buprenorphine-Naloxone Treatment for Opioid Dependence in Primary Care
  40. Pharmacoeconomics: Economic Evaluation of Pharmaceuticals
  41. Do consumers respond to publicly reported quality information? Evidence from nursing homes
  42. Geographic Variation in Implantable Cardioverter-Defibrillator Use and Heart Failure Survival
  43. Variations in Ambulance Use in the United States: The Role of Health Insurance
  44. Integration and Task Allocation: Evidence from Patient Care
  45. Problem solving to improve adherence and asthma outcomes in urban adults with moderate or severe asthma: A randomized controlled trial
  46. HEALTH SERVICE USE AMONG THE PREVIOUSLY UNINSURED: IS SUBSIDIZED HEALTH INSURANCE ENOUGH?
  47. Estimating treatment effects on healthcare costs under exogeneity: is there a ‘magic bullet’?
  48. Intervening To Improve Adherence And Asthma Outcomes In Urban Adults With Moderate Or Severe Asthma
  49. The Effect Of Pay-For-Performance In Hospitals: Lessons For Quality Improvement
  50. Medicare's Policy On Carotid Stents Limited Use To Hospitals Meeting Quality Guidelines Yet Did Not Hurt Disadvantaged
  51. Racial Differences in Surgeons and Hospitals for Endometrial Cancer Treatment
  52. Changes in Patient Sorting to Nursing Homes under Public Reporting: Improved Patient Matching or Provider Gaming?
  53. Response to McWilliams Commentary: “Assessing the Health Effects of Medicare Coverage for Previously Uninsured Adults: A Matter of Life and Death?”
  54. Cost-effectiveness of extended buprenorphine-naloxone treatment for opioid-dependent youth: data from a randomized trial
  55. Would Insuring Near-Elderly Persons Reduce Medicare Spending in Patients Aged 65 Years or Older?
  56. County-Level Variation in the Prevalence of Medicaid-Enrolled Children with Autism Spectrum Disorders
  57. The opportunity costs of screening children for asthma
  58. Design of comprehensive Alzheimer's disease centers to address unmet national needs
  59. Malpractice Premiums and the Supply of Obstetricians
  60. The Importance of Clinical Variables in Comparative Analyses Using Propensity-Score Matching
  61. Impact of Public Reporting on Quality of Postacute Care
  62. The Burden of Health Care Costs for Working Families — Implications for Reform
  63. The Health Effects of Medicare for the Near-Elderly Uninsured
  64. Costing and Cost Analysis in Randomized Controlled Trials
  65. The Impact of Consumer-Directed Health Plans and Patient Socioeconomic Status on Physician Recommendations for Colorectal Cancer Screening
  66. Use of Propensity Scores in Non-Linear Response Models: The Case for Health Care Expenditures
  67. Depression and Retirement in Late Middle-Aged U.S. Workers
  68. Short- and Long-Term Mortality after an Acute Illness for Elderly Whites and Blacks
  69. Valuing reductions in on-the-job illness: ‘presenteeism’ from managerial and economic perspectives
  70. POLSKY AND SOCHALSKI RESPOND
  71. POLSKY AND SOCHALSKI RESPOND
  72. Is Lower 30-Day Mortality Posthospital Admission Among Blacks Unique to the Veterans Affairs Health Care System?
  73. Is Thirty-Day Hospital Mortality Really Lower for Black Veterans Compared with White Veterans?
  74. Trends in Characteristics and Country of Origin Among Foreign-Trained Nurses in the United States, 1990 and 2000
  75. Clinical Trial-Based Cost-Effectiveness Analyses of Antipsychotic Use
  76. Clinical Trial-Based Cost-Effectiveness Analyses of Antipsychotic Use
  77. Variation in Chemotherapy Utilization in Ovarian Cancer: The Relative Contribution of Geography
  78. The Health Effects of Medicare for the Near-Elderly Uninsured
  79. Analyses of Cost Data in Economic Evaluations Conducted Alongside Randomized Controlled Trials
  80. Measuring the effects of work loss on productivity with team production
  81. Self-medication and health insurance coverage in Mexico
  82. Access to Health Care for Migrants Returning to Mexico
  83. Changes in Veterans’ Use of Outpatient Care From 1992 to 2000
  84. Differential Loss to Follow-up by Insurance Status in the Health and Retirement Study: Implications for National Estimates on Health Insurance Coverage
  85. Long-term Risk for Depressive Symptoms After a Medical Diagnosis
  86. Employer Health Insurance Offerings and Employee Enrollment Decisions
  87. Comparing the supply of pediatric subspecialists and child neurologists
  88. How to Present the Business Case for Healthcare Quality to Employers
  89. The Magnitude and Nature of Risk Selection in Employer-Sponsored Health Plans
  90. Accounting for Apparent “Reverse” Racial Disparities in Department of Veterans Affairs (VA)–Based Medical Care: Influence of Out-of-VA Care
  91. The 2004 Marshall Urist Award: Delays until Surgery after Hip Fracture Increases Mortality
  92. Response
  93. Measuring the Effects of Workloss on Productivity With Team Production
  94. Why Are Managed Care Plans Less Expensive: Risk Selection, Utilization, or Reimbursement?
  95. More intensive treatment of addiction does benefit society
  96. Strategies to attract medical students to the specialty of child neurology
  97. Morbidity and mortality of colorectal carcinoma surgery differs by insurance status
  98. Factors affecting decisions to seek treatment for sick children in Kerala, India
  99. Services Integration and Cost-Effectiveness
  100. Receipt of Health Services by Low-Income Veterans
  101. Design and analysis of unit cost estimation studies: How many hospital diagnoses? How many countries?
  102. An exploratory instrumental variable analysis of the outcomes of localized breast cancer treatments in a medicare population
  103. Patient Choice of Breast Cancer Treatment
  104. Initial Practice Locations of International Medical Graduates
  105. Duration of Therapy and Health Care Costs of Fluoxetine, Paroxetine, and Sertraline in 6 Health Plans
  106. Quantifying stochastic uncertainty and presenting results of cost-effectiveness analyses
  107. A comparison of scoring weights for the EuroQol derived from patients and the general public
  108. A comparison of scoring weights for the EuroQol� derived from patients and the general public
  109. HMO penetration and the geographic mobility of practicing physicians
  110. Has Job Stability Declined Yet? New Evidence for the 1990s
  111. Changing Consequences of Job Separation in the United States
  112. Self-Reported Physician Specialties and the Primary Care Content of Medical Practice
  113. Estimating country‐specific cost‐effectiveness from multinational clinical trials
  114. Economic Analysis of Tirilazad Mesylate for Aneurysmal Subarachnoid Hemorrhage: Economic Evaluation of a Phase III Clinical Trial in Europe and Australia
  115. Has Job Stability Declined Yet? New Evidence for the 1990's
  116. Confidence Intervals for Cost-Effectiveness Ratios: A Comparison of Four Methods
  117. Job Stability in the United States
  118. Comment on Kenneth A. Swinnerton and Howard Wial, "Is Job Stability Declining in the U.S. Economy?"
  119. Job Stability in the United States
  120. Selection Bias in Observational Data
  121. Integration and Task Allocation: Evidence from Patient Care
  122. Selection Bias in Observational Data
  123. Pharmacoeconomics: Economic Evaluation of Pharmaceuticals
  124. Pharmacoeconomics: Economic Evaluation of Pharmaceuticals
  125. Shipping Out Instead of Shaping Up: Rehospitalization from Nursing Homes as an Unintended Effect of Public Reporting